Amarin Corporation
AMRN
#7960
Rank
NZ$0.51 B
Marketcap
NZ$24.77
Share price
-3.24%
Change (1 day)
18.95%
Change (1 year)

Earnings for Amarin Corporation (AMRN)

Earnings in 2025 (TTM): -NZ$0.15 Billion

According to Amarin Corporation 's latest financial reports the company's current earnings are NZ$0.22 Billion. In 2024 the company made an earning of -NZ$0.13 Billion a decrease over its 2023 earnings that were of -NZ$89.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amarin Corporation from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.15 Billion15.93%
2024 -NZ$0.13 Billion43.84%
2023 -NZ$89.12 Million-48.3%
2022 -NZ$0.18 Billion-1019.36%
2021 NZ$18.74 M-165.44%
2020 -NZ$28.66 Million-23.25%
2019 -NZ$37.33 Million-80.68%
2018 -NZ$0.2 Billion112.25%
2017 -NZ$91.02 Million-28.23%
2016 -NZ$0.13 Billion-35.43%
2015 -NZ$0.2 Billion99.81%
2014 -NZ$98.3 Million-65.06%
2013 -NZ$0.29 Billion-0.38%
2012 -NZ$0.29 Billion-150.87%
2011 NZ$0.55 B-233.68%
2010 -NZ$0.42 Billion
2007 -NZ$64.82 Million44.04%
2006 -NZ$45 Million
2004 -NZ$24.32 Million-46.41%
2003 -NZ$45.37 Million-41.09%
2002 -NZ$77.01 Million813.31%
2001 -NZ$8.44 Million113.63%
2000 -NZ$3.95 Million
1998 -NZ$28.07 Million98.82%
1997 -NZ$14.12 Million-50.29%
1996 -NZ$28.4 Million-1321.43%
1995 NZ$2.32 M-94.53%
1994 NZ$42.5 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
NZ$2.75 B-2,050.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$21.73 B-15,481.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$15.47 B-11,054.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
NZ$0.67 B-576.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
NZ$2.94 B-2,182.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel